STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXAS
  4. [144] Exact Sciences Corp SEC Filing

[144] Exact Sciences Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock EXAS logo
Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

#1035 Ranked by Market Cap
N/A Ranked by Dividends

EXAS Latest News

Aug 6, 2025
Exact Sciences Announces Second Quarter 2025 Results
Aug 6, 2025
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
Jul 31, 2025
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test
Jul 14, 2025
Exact Sciences Schedules Second Quarter 2025 Earnings Call
Jul 9, 2025
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer

EXAS Latest SEC Filings

Aug 7, 2025
[Form 4] Exact Sciences Corp Insider Trading Activity
Aug 7, 2025
[Form 4] Exact Sciences Corp Insider Trading Activity
Aug 6, 2025
[10-Q] Exact Sciences Corp Quarterly Earnings Report
Aug 6, 2025
[8-K] Exact Sciences Corp Reports Material Event
Jul 11, 2025
[S-8 POS] Exact Sciences Corp SEC Filing

EXAS Stock Data

8.88B
186.89M
0.91%
99.21%
3.96%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MADISON